Who should sponsor sleep disorders pharmaceutical trials?

J Clin Sleep Med. 2007 Dec 15;3(7):671-3.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Azabicyclo Compounds / adverse effects
  • Azabicyclo Compounds / therapeutic use
  • Bias
  • Conflict of Interest*
  • Controlled Clinical Trials as Topic / ethics*
  • Controlled Clinical Trials as Topic / statistics & numerical data
  • Drug Industry / ethics*
  • Eszopiclone
  • Humans
  • Hypnotics and Sedatives / adverse effects
  • Hypnotics and Sedatives / therapeutic use*
  • National Institutes of Health (U.S.)
  • Piperazines / adverse effects
  • Piperazines / therapeutic use
  • Research Support as Topic / ethics*
  • Restless Legs Syndrome / drug therapy
  • Sleep Wake Disorders / drug therapy*
  • Treatment Outcome
  • United States
  • United States Department of Veterans Affairs
  • United States Food and Drug Administration

Substances

  • Azabicyclo Compounds
  • Hypnotics and Sedatives
  • Piperazines
  • Eszopiclone